Cytox Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Cytox Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10311
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cytox Ltd (Cytox) is a prognostic and diagnostic service provider that develops neurodegenerative disorders services. The company offers development of tests to identify individuals at risk of cognitive decline, Alzheimer’s disease and other dementias and its blood tests are used to predict that patients with MCI will develop Alzheimer’s disease. Its biomarkers are based on the cell cycle hypothesis of Alzheimer’s disease discovered. Cytox offers Cytox variatech SNP research assay that is a biomarker research assay to reduce screening failure in clinical trials and helps in novel drug discovery. The company also provides biomarker services to pharmaceutical industry clients to conduct clinical trials with drugs for the treatment of Alzheimer’s disease and mild cognitive impairment. It partners with pharmaceutical industry and academic researchers to develop blood-based assays. Cytox is headquartered in Oxford, the UK.

Cytox Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cytox Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cytox Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cytox Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cytox Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Cytox Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cytox Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
Cytox Raises USD3.3 Million in Venture Financing 10
Cytox Raises US$2.5 Million In Venture Financing 12
Cytox Raises USD5.5 Million in Financing Round 13
Partnerships 14
Cytox Enters into Joint Development Partnership with Affymetrix 14
Alta Innovations Enters Into Licensing Agreement With Cytox 15
Cytox Ltd – Key Competitors 16
Cytox Ltd – Key Employees 17
Cytox Ltd – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Strategy And Business Planning 19
May 08, 2018: Cytox in collaboration with AKESOgen extends genetic test for assessing Alzheimer s disease risk to include saliva samples 19
Other Significant Developments 20
May 22, 2018: Cytox launches collaboration agreement with Mayo Clinic to evaluate novel genetic based approaches for assessing Alzheimer’s risk 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Cytox Ltd, Medical Equipment, Key Facts 2
Cytox Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Cytox Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cytox Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cytox Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cytox Ltd, Deals By Market, 2012 to YTD 2018 8
Cytox Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cytox Raises USD3.3 Million in Venture Financing 10
Cytox Raises US$2.5 Million In Venture Financing 12
Cytox Raises USD5.5 Million in Financing Round 13
Cytox Enters into Joint Development Partnership with Affymetrix 14
Alta Innovations Enters Into Licensing Agreement With Cytox 15
Cytox Ltd, Key Competitors 16
Cytox Ltd, Key Employees 17

List of Figures
Cytox Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Cytox Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Cytox Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Cytox Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Cytox Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cytox Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Cytox Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cytox Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Cytox Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ivy Cosmetics Corporation:企業の戦略・SWOT・財務情報
    Ivy Cosmetics Corporation - Strategy, SWOT and Corporate Finance Report Summary Ivy Cosmetics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Sinofert Holdings Ltd (297):企業の財務・戦略的SWOT分析
    Sinofert Holdings Ltd (297) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • L E Pritchitt & Co Ltd. :企業の戦略・SWOT・財務情報
    L E Pritchitt & Co Ltd. - Strategy, SWOT and Corporate Finance Report Summary L E Pritchitt & Co Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • SINTX Technologies Inc (SINT):企業の財務・戦略的SWOT分析
    SINTX Technologies Inc (SINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Tarsa Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tarsa Therapeutics Inc (Tarsa) is a developer of therapies for the treatment and prevention of osteoporosis and other bone related diseases. The company develops calcitonin tablet TBRIA, an oral formulation of calcitonin, a peptide hormone that inhibits bone resorption, which is used for the …
  • Taisho Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Taisho Pharmaceutical Co Ltd (Taisho), a subsidiary of Taisho Pharmaceutical Holdings Co Ltd is a pharmaceutical company that develops, manufactures and markets a range of prescription pharmaceutical and self-medication drugs. The company offers products that include lipovitan D, riup, clari …
  • Entertainment One Ltd.:企業の戦略・SWOT・財務分析
    Entertainment One Ltd. - Strategy, SWOT and Corporate Finance Report Summary Entertainment One Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Autoridad del Canal de Panama:企業の戦略的SWOT分析
    Autoridad del Canal de Panama - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Orphazyme AS (ORPHA):製薬・医療:M&Aディール及び事業提携情報
    Summary Orphazyme A/S (Orphazyme) formerly Orphazyme ApS, is a biopharmaceutical company that develops heat shock protein based therapies for the treatment of orphan protein-misfolding diseases. Its lead product drug candidate arimoclomol is under clinical development for treating neuromuscular dise …
  • Arcelik A.S. (ARCLK):企業の財務・戦略的SWOT分析
    Arcelik A.S. (ARCLK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nanovis Inc-医療機器分野:企業M&A・提携分析
    Summary Nanovis Inc (Nanovis) is a medical device company that develops and markets tissue regenerating implants for bone and soft tissues. The company provides products such as implant nanosurfaces, implantable scaffolds and cervical plate, among others. Nanovis offers products PEEK interbody syste …
  • Automotive Holdings Group Limited:企業のM&A・事業提携・投資動向
    Automotive Holdings Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Automotive Holdings Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Proteon Therapeutics Inc (PRTO):製薬・医療:M&Aディール及び事業提携情報
    Summary Proteon Therapeutics Inc (Proteon Therapeutics) is a late-stage biopharmaceutical company that develops pharmaceutical products for the treatment of renal and vascular diseases. The company develops investigational therapies to treat hemodialysis and peripheral artery disease patients. Its p …
  • Alliant Energy Corporation:企業の戦略・SWOT・財務分析
    Alliant Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Alliant Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Adira Energy Ltd (ADENF):石油・ガス:M&Aディール及び事業提携情報
    Summary Adira Energy Ltd (Adira Energy) is an oil and gas company that acquires and explores crude oil and natural gas resource properties. The company undertakes oil and gas projects across Israel. It also holds interest in three offshore petroleum projects in Yitzhak, Gabriella, and Samuel. Adira …
  • Mereo Biopharma Group Plc (MPH):企業の財務・戦略的SWOT分析
    Summary Mereo Biopharma Group Plc (Mereo), formerly Mereo Biopharma Group Ltd is a specialty bio-pharmaceutical company which develops novel medicines for the treatment of rare and specialty diseases. The company’s pipeline products include BPS-804, which is used for the treatment of brittle bone sy …
  • Sunstone Hotel Investors, Inc.:企業のM&A・事業提携・投資動向
    Sunstone Hotel Investors, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sunstone Hotel Investors, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Baker IDI Heart and Diabetes Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Baker IDI Heart and Diabetes Institute (Baker Institute) is a medical research organization that offers diagnosis, prevention, treatment of diabetics and cardiovascular disease. The organization offers clinical services such as diabetes services, weight assessment and management clinic healt …
  • SATCO Products Inc:企業の戦略的SWOT分析
    SATCO Products Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • New Zealand Oil & Gas Ltd (NZO):企業の財務・戦略的SWOT分析
    Summary New Zealand Oil & Gas Ltd (NZOG) is an oil and gas exploration, development and production company. It acquires, explores, and develops crude oil and natural gas properties. NZOG’s producing assets include Maari and Manaia fields, Kupe gas and light oil field, and Sampang PSC. The company pa …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆